« Previous article

21st September 2020  Product update: rapidmicrobiology staff writer

Rapid COVID-19 Antigen Test Card Suitable for On-the-Spot Testing

Lepu Medical (Beijing Lepu Medical Technology) has obtained CE-Marking for its Colloidal-Gold Immunochromatography SARS-CoV-2 Rapid Antigen Test.

The assay detects the nucleocapsid (N) protein of the virus, a target used extensively in SARS-CoV-2 vaccine development.

The kit, which is presented in card-like format, contains gold-labelled SARS-CoV-2 N protein monoclonal antibodies immobilized on the test area, with corresponding antibodies in the quality control area.

The test card takes swabbed specimens from the nasopharynx or oropharyngeal in through two wells embedded in the card.

The swab is twisted clockwise and anti-clockwise twice, and the clinician then folds over the card and waits 15 minutes for a result.

The higher the volume of N protein in the sample the darker the colour test area, which needs to be viewed with UV light.

The company says the test can pick viral loads even in early phases i.e incubation.



Date Published: 21st September 2020

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.

View full company details

Get our eNewsletter
Over 6,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!